STOCKHOLM, April 22, 2022 /PRNewswire/ The shareholders of Cantargia AB (publ) are invited to the annual general meeting on Monday, 23 May 2022, at 16.00 CET at Ideon Gateway, Scheelevägen
The shareholders of Affibody Medical AB (publ), corporate identity number 556714-5601 (the “Company” or “Affibody”) are hereby invited to attend the annual.
STOCKHOLM, Oct. 15, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological